Myoclonic dystonia
Myoclonic dystonia is a neurological disorder characterized by rapid, jerking movements (myoclonus) and/or sustained twisting and repetitive movements that result in abnormal postures (dystonia). The condition is typically inherited in an autosomal dominant manner and is caused by mutations in the SGCE gene.
Symptoms
The symptoms of myoclonic dystonia usually appear in childhood or adolescence and may include rapid, jerking movements (myoclonus) and/or sustained twisting and repetitive movements that result in abnormal postures (dystonia). The myoclonus in this condition primarily affects the upper body, neck, and arms. The severity and distribution of the dystonia can vary, but it often affects the hands and may cause difficulties with writing (writer's cramp). Some affected individuals may have mild, non-progressive cognitive impairment. Anxiety and depression are also common in people with myoclonic dystonia.
Causes
Myoclonic dystonia is caused by mutations in the SGCE gene. This gene provides instructions for making a protein that is found in many of the body's tissues, but its function is not well understood. It is thought to play a role in the normal function of nerve cells, particularly in the brain.
Diagnosis
The diagnosis of myoclonic dystonia is based on the clinical symptoms, the presence of similar symptoms in family members (suggesting an inherited condition), and genetic testing confirming a mutation in the SGCE gene.
Treatment
Treatment for myoclonic dystonia is symptomatic and may include medications such as benzodiazepines, anticholinergics, and botulinum toxin injections. In some cases, deep brain stimulation may be considered.
Prognosis
The prognosis for individuals with myoclonic dystonia varies. Some people may have mild symptoms and require minimal treatment, while others may have more severe symptoms that significantly affect their quality of life.
See also
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


